Atorvastatin
Properties
- Molecular formula
- C33H35FN2O5
- Molar mass
- 558.65 g/mol
- Exact mass
- 558.2530 Da
- Melting point
- 159.1–190.6 °C
- pKa
- 4.46
- logP
- 6.31Crippen estimate
- Polar surface area
- 111.8 Ų
- H-bond donors / acceptors
- 4 / 4
- Rotatable bonds
- 12
- Stereocentres
- R, Rin SMILES atom order
Hazards
Warning
- H315 Causes skin irritation66.7% of notifiers
- H319 Causes serious eye irritation66.7% of notifiers
- H335 May cause respiratory irritation66.7% of notifiers
- H361 Suspected of damaging fertility or the unborn child33.3% of notifiers
- H361f Suspected of damaging fertility33.3% of notifiers
- H361fd Suspected of damaging fertility; Suspected of damaging the unborn child33.3% of notifiers
- H362 May cause harm to breast-fed children66.7% of notifiers
Aggregated from 3 ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Precautionary statements
P203, P260, P261, P263, P264, P264+P265, P270, P271, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, P501
Identifiers
CAS number
110862-48-1SMILES
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4InChIKey
XUKUURHRXDUEBC-KAYWLYCHSA-NInChI
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1Characterization data
Calculated from the structure, in the form journals print them.
¹H NMR
Predicted ¹H NMR (400 MHz, CDCl₃) δ 11.50 (br s, 1H), 7.73 (dd, J = 7.7 Hz, J(H,F) = 5.5 Hz, 2H), 7.73 (dd, J = 7.7, 1.6 Hz, 2H), 7.56 (m, J = 7.7 Hz, 2H), 7.48 (dd, J = 7.7, 1.6 Hz, 2H), 7.46 (m, J = 7.7, 1.6 Hz, 1H), 7.40 (br s, 1H), 7.30 (dd, J = 7.7 Hz, J(H,F) = 8.8 Hz, 2H), 7.29 (t, J = 7.7 Hz, 2H), 7.08 (tt, J = 7.7, 1.6 Hz, 1H), 4.32 (quint, J = 7.0 Hz, 1H), 4.02 (quint, J = 7.0 Hz, 1H), 3.95 (t, J = 7.0 Hz, 2H), 2.89 (sept, J = 7.0 Hz, 1H), 2.74 (d, J = 7.0 Hz, 2H), 2.18 (q, J = 7.0 Hz, 2H), 2.00 (br s, 1H), 2.00 (br s, 1H), 1.99 (t, J = 7.0 Hz, 2H), 1.21 (d, J = 7.0 Hz, 6H).¹³C NMR
Predicted ¹³C NMR (101 MHz, CDCl₃) δ 180.3, 166.8, 162.5 (d, J(C,F) = 245.0 Hz), 141.4, 138.1, 138.1, 136.9 (d, J(C,F) = 3.2 Hz), 130.2, 128.9, 128.6, 128.2 (d, J(C,F) = 8.0 Hz), 127.4, 127.3, 124.0, 120.3, 118.9, 114.6 (d, J(C,F) = 21.0 Hz), 110.6, 63.6, 60.5, 44.6, 43.3, 42.0, 40.0, 38.0, 24.4.[M + H]+
[M + H]+ Calcd for C33H36FN2O5 559.2603[M + Na]+
[M + Na]+ Calcd for C33H35FN2NaO5 581.2422[M − H]−
[M − H]− Calcd for C33H34FN2O5 557.2457Elemental analysis
Anal. Calcd for C33H35FN2O5: C, 70.95; H, 6.32; N, 5.01.Weigh it out
Type any one amount. The others follow from the molar mass.
Work with Atorvastatin
Stereoisomers, salts and isotopologues
The same compound in another form: other stereochemistry, a salt or hydrate, the free acid or base, or an isotope-labelled version.
Atorvastatin calcium134523-03-8Salt
Atorvastatin hemicalcium trihydrate344423-98-9Salt
Atorvastatin sodium134523-01-6Salt
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βS,δS)-1105067-88-6Salt, enantiomer
Atorvastatin134523-00-5
Similar compounds
Atorvastatin methyl ester345891-62-580 % similar
Atorvastatin tert-butyl ester134395-00-977 % similar
Atorvastatin lactone125995-03-176 % similar
Calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoate)887196-29-470 % similar
2-Hydroxy atorvastatin calcium salt265989-46-665 % similar
1,1-Dimethylethyl (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate125971-95-160 % similar
Fluvastatin93957-54-141 % similar
Cerivastatin145599-86-638 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.